Field Stories
Centering women’s voices to drive meaningful change
March 5, 2025
This brief summarizes the results and implications of new evidence around WHO recommended WIFAS containing 2.8 mg folic acid and its association with a lower risk of neural tube defects than the current practice of 0.4 mg folic acid. Including the WHO-recommended WIFAS dose on the WHO model EML could improve its availability and affordability for use in WIFAS programs by guiding national EMLs and thus purchasing and supply management decisions.